Anaemia in ICU patient. Vampirism in critical care. Unnecessary bloodletting draws. Iatrogenic anaemia. Secondary anaemia. Do not do recommendations to avoid unnecessary analytics
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
Greenberg et al-2015-anesthesia_&_analgesiasamirsharshar
This editorial discusses the ongoing controversy around the safety of hydroxyethyl starch (HES) for perioperative fluid therapy. While HES has been used clinically for over 40 years, recent large trials in sepsis patients found an association with renal failure and need for renal replacement therapy. However, the risk appears greater in more critically ill patients. Two new studies presented in the journal found mixed results - one in lower risk patients found no renal effects, while another in higher risk liver transplant patients found a dose-dependent increased risk of acute kidney injury with HES. The editorial concludes that more research is still needed to determine safety in different patient populations and clinical contexts of HES use.
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
This three-part document discusses hemodialysis prescription and targets. It begins with an introduction and overview of hemodialysis history and statistics on end-stage renal disease from the USRDS 2020 report. Part I covers breaking the news to patients about needing dialysis and variables in deciding on dialysis. Parts II and III will discuss choosing filters and dialysate composition, hemodynamics, ultrafiltration, and research aspects of optimizing hemodialysis prescription. The goal is targeting a dialysis treatment that is friendly to patients.
Access vs non-access site bleeding and risk of subsequent mortality and MACE
This study aimed to analyze the incidence and prognostic impact of access site versus non-access site bleeding in patients undergoing percutaneous coronary intervention (PCI). The meta-analysis included 38 studies and over 520,000 patients. It found that access site bleeding occurred in 11.2% of patients while non-access site bleeding occurred in 10.2% of patients. However, non-access site bleeding was associated with a higher crude mortality rate of 8.3% compared to 2.8% for access site bleeding. Further analyses confirmed that non-access site bleeding carried a greater risk of subsequent mortality and major adverse cardiac events than access site bleeding. The
Ascitis y cirrosis. guías 2009 update6 2009Daejam Geum
This document provides guidelines for the management of adult patients with ascites due to cirrhosis. It summarizes the evaluation and diagnosis process. Key points include:
- Abdominal paracentesis with ascitic fluid analysis is recommended for patients with clinically apparent new-onset ascites to confirm the diagnosis and determine the cause.
- Routine tests of coagulation do not accurately predict bleeding risk in patients with cirrhosis. Prophylactic transfusions before paracentesis are not recommended.
- Ascitic fluid should be analyzed to determine if the fluid is due to portal hypertension or another cause. Further testing may be done if initial screening tests yield abnormal results.
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
Greenberg et al-2015-anesthesia_&_analgesiasamirsharshar
This editorial discusses the ongoing controversy around the safety of hydroxyethyl starch (HES) for perioperative fluid therapy. While HES has been used clinically for over 40 years, recent large trials in sepsis patients found an association with renal failure and need for renal replacement therapy. However, the risk appears greater in more critically ill patients. Two new studies presented in the journal found mixed results - one in lower risk patients found no renal effects, while another in higher risk liver transplant patients found a dose-dependent increased risk of acute kidney injury with HES. The editorial concludes that more research is still needed to determine safety in different patient populations and clinical contexts of HES use.
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
This three-part document discusses hemodialysis prescription and targets. It begins with an introduction and overview of hemodialysis history and statistics on end-stage renal disease from the USRDS 2020 report. Part I covers breaking the news to patients about needing dialysis and variables in deciding on dialysis. Parts II and III will discuss choosing filters and dialysate composition, hemodynamics, ultrafiltration, and research aspects of optimizing hemodialysis prescription. The goal is targeting a dialysis treatment that is friendly to patients.
Access vs non-access site bleeding and risk of subsequent mortality and MACE
This study aimed to analyze the incidence and prognostic impact of access site versus non-access site bleeding in patients undergoing percutaneous coronary intervention (PCI). The meta-analysis included 38 studies and over 520,000 patients. It found that access site bleeding occurred in 11.2% of patients while non-access site bleeding occurred in 10.2% of patients. However, non-access site bleeding was associated with a higher crude mortality rate of 8.3% compared to 2.8% for access site bleeding. Further analyses confirmed that non-access site bleeding carried a greater risk of subsequent mortality and major adverse cardiac events than access site bleeding. The
Ascitis y cirrosis. guías 2009 update6 2009Daejam Geum
This document provides guidelines for the management of adult patients with ascites due to cirrhosis. It summarizes the evaluation and diagnosis process. Key points include:
- Abdominal paracentesis with ascitic fluid analysis is recommended for patients with clinically apparent new-onset ascites to confirm the diagnosis and determine the cause.
- Routine tests of coagulation do not accurately predict bleeding risk in patients with cirrhosis. Prophylactic transfusions before paracentesis are not recommended.
- Ascitic fluid should be analyzed to determine if the fluid is due to portal hypertension or another cause. Further testing may be done if initial screening tests yield abnormal results.
Central venous pressure (CVP) is commonly used to guide fluid management, but its ability to predict fluid responsiveness is questionable. This systematic review analyzed 24 studies involving 803 patients. The review found a very poor relationship between CVP and blood volume. CVP was also unable to accurately predict a patient's fluid responsiveness, defined as an increase in stroke volume or cardiac index in response to fluid administration. The review demonstrated that CVP should not be used to make clinical decisions about fluid management.
1) A study of 455 patients undergoing transradial cardiac catheterization found that the rate of radial artery occlusion (RAO) was significantly higher when a 6-French sheath was used (30.5%) compared to a 5-French sheath (13.7%).
2) Multivariate analysis identified female sex, younger age, presence of peripheral artery disease, and use of a 6-French sheath as independent predictors of RAO.
3) For patients who developed symptomatic RAO, treatment with low molecular weight heparin showed a higher rate of recanalization (55.6%) compared to patients who did not receive anticoagulation (13.5%).
The document summarizes economic analyses that have found transradial procedures to be more cost-effective than transfemoral procedures. Several studies are highlighted, including a registry analysis finding lower total inpatient costs and shorter length of stay for transradial PCI. A meta-analysis found transradial procedures were associated with lower complication rates and costs. For STEMI patients, studies demonstrated transradial procedures were linked to shorter hospital stays. The conclusions state that transradial access can improve value by enhancing outcomes and reducing length of stay, creating value across clinical scenarios.
Hot Topics in ICM - PINCER Course 25th sept 2015Steve Mathieu
Presentation by Steve Mathieu @stevemathieu75
Hot Topics presentation from Portsmouth INtensive Care Exam Revision (PINCER) Course http://www.wessexics.com/Wessex_ICM_Courses/PINCER_FFICM_Revision_Course/
Antibiotic dose modification is crucial on patients with CRRT with sepsis and MOF. This talk highlights the importance of achieving plasma therapeutic drug concentration in ICU patients to enhance their chances of survival while on CRRT
he Citrate Story
David Gattas gives an update on today's go-to anti-coagulant for renal replacement therapy: Citrate
David is a key figure in the ANZICS CTG, with a growing list of publications and was involved in the RENAL and POST-RENAL studies.
Long-Term Survival and Dialysis Dependency Following Acute Kidney Injury in Intensive Care: Extended Follow-up of a Randomized Controlled Trial is available free.
This talk was recorded live at an ICN NSW / ANZICS meeting in September 2014.
Same Wrist Intervention via the Cubital (Ulnar) Artery in Case of Radial Puncture Failure for Percutaneous Cardiac Catheterization or Intervention: The Multicenter Prospective SWITCH Registry
COMPARISION OF SERUM LACTATE AND BASE DEFICIT AS INDICATORS OF ADEQUATE FLUI...Srihari Cattamanchi
This study compared serum lactate and base deficit as indicators of adequate fluid resuscitation and prognosis in trauma patients with hypovolemic shock. The study found that lactate level was superior to base deficit as a marker for shock and resuscitation. Lactate normalization time and lactate clearance were both very good predictors of mortality and good indicators for adequate fluid resuscitation in trauma patients with hypovolemic shock. Patients whose lactate levels normalized within 24 hours survived, those between 24-48 hours had an 83.3% survival rate, while those over 48 hours only had a 20% survival rate.
This document discusses different methods used to quantify the dose of hemodialysis received by patients. It describes how urea is commonly used as a surrogate marker for measuring dialysis dose, despite not being the actual uremic toxin. Three main methods are outlined: urea reduction ratio, calculating Kt/V from urea reduction, and urea kinetic modeling using computer programs. Potential issues with solely relying on urea and assuming a single-pool model for distribution are also presented, such as overestimating the true dose of dialysis received.
This meta-analysis compared the effectiveness of surgical procedures for portal hypertension, including selective or nonselective shunts, devascularization, and combined shunt and devascularization. It found that shunt procedures were more effective at reducing rebleeding compared to devascularization alone, but also carried a higher risk of encephalopathy. Combined shunt and devascularization was more effective at reducing portal vein pressure and rebleeding than devascularization alone. There were no significant differences in outcomes between selective and nonselective shunts. The analysis was based on data from randomized controlled trials involving over 1000 patients with portal hypertension.
This symposium provides an overview of the (r)evolution in intensive care medicine. The programme is based on lectures of 20 minutes where each speaker presents in two 10 minute talks (in der Beschränkung zeigt sich erst der Meister) the good things that happened in the last 40 years in critical care vs our mistakes or what is missing with respect to that topic. At the end of the session the speakers participate in an interactive round table discussion with online voting to get the audience involved. Will be discussed: Theoretical concepts, basic physiology and pathophysiology, monitoring, and future directions.
This document discusses various aspects of renal replacement therapy for acute kidney injury. It begins by outlining the stage-based management of AKI, with increasing intervention and monitoring recommended as the stage progresses from risk to injury to failure. The document then addresses indications for starting renal replacement therapy, appropriate modalities including intermittent hemodialysis, slow continuous ultrafiltration, and continuous renal replacement therapy. Key factors like vascular access, solutions, membranes, anticoagulation, and dose are discussed. The overall conclusions are that while data from high-quality randomized controlled trials are still lacking, earlier initiation of renal replacement therapy may aid recovery, and continuous modalities are generally preferred over intermittent hemodialysis for unstable patients. Individualization of
This document provides an introduction, history, and indications for continuous renal replacement therapy (CRRT). It summarizes that CRRT was developed as an alternative to intermittent hemodialysis for critically ill patients. CRRT allows for slow, continuous removal of waste and fluid over many hours compared to brief, intermittent hemodialysis sessions. The document reviews the components of CRRT systems and indications for its use in critically ill patients with conditions like fluid overload, acidosis, hyperkalemia, or multi-organ dysfunction.
The patient is a 49-year-old woman with end-stage renal disease and diabetes who presented with altered mental status. She receives hemodialysis three times per week for a few years. Recently, she has been increasingly tired, weak, and unable to perform daily activities with poor appetite and nausea. On examination, she was pale and swollen with low hemoglobin. Tests found elevated creatinine, BUN, and electrolyte abnormalities. The most probable diagnosis is inadequate hemodialysis, as her symptoms and labs are consistent with worsening uremia due to insufficient solute clearance from her dialysis sessions. Kt/V is a measure of dialysis adequacy that accounts for urea clearance and patient
Value Analysis Committee Presentation - PleuraFlow® ACT® SystemPaul Molloy
Presentation explaining how the PleuraFlow® ACT® System from ClearFlow,Inc.can Reduce Complications and Costs for your Cardiothoracic surgery patients.
This document discusses continuous renal replacement therapy (CRRT) for acute kidney injury (AKI). It begins by defining CRRT and describing its indications, including life-threatening conditions like hyperkalemia and pulmonary edema. It recommends starting CRRT early in AKI and discusses modalities like CVVH, CVVHD, and CVVHDF. The document provides details on how to perform CRRT, such as catheter placement and settings. It also addresses complications and suggests using bicarbonate-based fluids and biocompatible membranes. In summary, the document provides a comprehensive overview of CRRT for AKI, including indications, modalities, procedures, and recommendations to optimize outcomes.
The Emerging Role of BIomarkers and Bio-Impedancedrucsamal
This document discusses methods for assessing hydration status in patients with acute heart failure. It reviews classical assessment methods like history, physical exam, imaging techniques, and isotopic tracers, which is the gold standard but impractical. It then focuses on emerging roles of biomarkers and bioimpedance analysis which provide a less invasive way to estimate total body water content and fluid overload. These novel methods show promise for diagnosing, risk-stratifying, and guiding treatment decisions for acute heart failure patients.
Dr. Frederic Michard discusses perioperative fluid management and optimization. He advocates using pulse pressure variation (PPV) or stroke volume variation (SVV) to guide fluid administration when possible. When those values cannot be used, stroke volume response to fluid challenges should be monitored. Compliance to fluid optimization protocols is important. Graphical displays and checklists may improve compliance, while closed-loop systems could achieve near 100% compliance, but their safety requires further clinical studies.
The document outlines the objectives and key concepts of a training course on continuous renal replacement therapy (CRRT). It defines CRRT and discusses the basic principles of CRRT, including solute transport mechanisms, clinical indications, machine setup and safety features, and fluid balance principles. It also summarizes evidenced-based research showing improved patient survival with early CRRT initiation and adequate dose delivery.
Comparison Between Antiviral Combination Therapies Against Hepatitis C Virus ...Mohammed Fathy Zaky
This document appears to be a thesis submitted for a degree from the Faculty of Medicine at Ain Shams University in Egypt. It summarizes a clinical study that compared the efficacy and safety of different antiviral combination therapies for hepatitis C virus genotype 4 in 1000 Egyptian patients. The study found overall sustained virological response rates above 95% for all treatment regimens. Sofosbuvir combined with ledipasvir or daclatasvir showed the highest response rates, while sofosbuvir with pegylated interferon and ribavirin showed the lowest. Baseline factors like higher albumin, platelets and lower bilirubin, AFP, and fibrosis scores predicted treatment success.
Evolution of blood transfusion in Hospital General San Jorge
Change in blood consume during ten years.
Red cell concentrate, platelets and plasma reduction is possible
Patient Blood Management and Transfusion with common sense
Central venous pressure (CVP) is commonly used to guide fluid management, but its ability to predict fluid responsiveness is questionable. This systematic review analyzed 24 studies involving 803 patients. The review found a very poor relationship between CVP and blood volume. CVP was also unable to accurately predict a patient's fluid responsiveness, defined as an increase in stroke volume or cardiac index in response to fluid administration. The review demonstrated that CVP should not be used to make clinical decisions about fluid management.
1) A study of 455 patients undergoing transradial cardiac catheterization found that the rate of radial artery occlusion (RAO) was significantly higher when a 6-French sheath was used (30.5%) compared to a 5-French sheath (13.7%).
2) Multivariate analysis identified female sex, younger age, presence of peripheral artery disease, and use of a 6-French sheath as independent predictors of RAO.
3) For patients who developed symptomatic RAO, treatment with low molecular weight heparin showed a higher rate of recanalization (55.6%) compared to patients who did not receive anticoagulation (13.5%).
The document summarizes economic analyses that have found transradial procedures to be more cost-effective than transfemoral procedures. Several studies are highlighted, including a registry analysis finding lower total inpatient costs and shorter length of stay for transradial PCI. A meta-analysis found transradial procedures were associated with lower complication rates and costs. For STEMI patients, studies demonstrated transradial procedures were linked to shorter hospital stays. The conclusions state that transradial access can improve value by enhancing outcomes and reducing length of stay, creating value across clinical scenarios.
Hot Topics in ICM - PINCER Course 25th sept 2015Steve Mathieu
Presentation by Steve Mathieu @stevemathieu75
Hot Topics presentation from Portsmouth INtensive Care Exam Revision (PINCER) Course http://www.wessexics.com/Wessex_ICM_Courses/PINCER_FFICM_Revision_Course/
Antibiotic dose modification is crucial on patients with CRRT with sepsis and MOF. This talk highlights the importance of achieving plasma therapeutic drug concentration in ICU patients to enhance their chances of survival while on CRRT
he Citrate Story
David Gattas gives an update on today's go-to anti-coagulant for renal replacement therapy: Citrate
David is a key figure in the ANZICS CTG, with a growing list of publications and was involved in the RENAL and POST-RENAL studies.
Long-Term Survival and Dialysis Dependency Following Acute Kidney Injury in Intensive Care: Extended Follow-up of a Randomized Controlled Trial is available free.
This talk was recorded live at an ICN NSW / ANZICS meeting in September 2014.
Same Wrist Intervention via the Cubital (Ulnar) Artery in Case of Radial Puncture Failure for Percutaneous Cardiac Catheterization or Intervention: The Multicenter Prospective SWITCH Registry
COMPARISION OF SERUM LACTATE AND BASE DEFICIT AS INDICATORS OF ADEQUATE FLUI...Srihari Cattamanchi
This study compared serum lactate and base deficit as indicators of adequate fluid resuscitation and prognosis in trauma patients with hypovolemic shock. The study found that lactate level was superior to base deficit as a marker for shock and resuscitation. Lactate normalization time and lactate clearance were both very good predictors of mortality and good indicators for adequate fluid resuscitation in trauma patients with hypovolemic shock. Patients whose lactate levels normalized within 24 hours survived, those between 24-48 hours had an 83.3% survival rate, while those over 48 hours only had a 20% survival rate.
This document discusses different methods used to quantify the dose of hemodialysis received by patients. It describes how urea is commonly used as a surrogate marker for measuring dialysis dose, despite not being the actual uremic toxin. Three main methods are outlined: urea reduction ratio, calculating Kt/V from urea reduction, and urea kinetic modeling using computer programs. Potential issues with solely relying on urea and assuming a single-pool model for distribution are also presented, such as overestimating the true dose of dialysis received.
This meta-analysis compared the effectiveness of surgical procedures for portal hypertension, including selective or nonselective shunts, devascularization, and combined shunt and devascularization. It found that shunt procedures were more effective at reducing rebleeding compared to devascularization alone, but also carried a higher risk of encephalopathy. Combined shunt and devascularization was more effective at reducing portal vein pressure and rebleeding than devascularization alone. There were no significant differences in outcomes between selective and nonselective shunts. The analysis was based on data from randomized controlled trials involving over 1000 patients with portal hypertension.
This symposium provides an overview of the (r)evolution in intensive care medicine. The programme is based on lectures of 20 minutes where each speaker presents in two 10 minute talks (in der Beschränkung zeigt sich erst der Meister) the good things that happened in the last 40 years in critical care vs our mistakes or what is missing with respect to that topic. At the end of the session the speakers participate in an interactive round table discussion with online voting to get the audience involved. Will be discussed: Theoretical concepts, basic physiology and pathophysiology, monitoring, and future directions.
This document discusses various aspects of renal replacement therapy for acute kidney injury. It begins by outlining the stage-based management of AKI, with increasing intervention and monitoring recommended as the stage progresses from risk to injury to failure. The document then addresses indications for starting renal replacement therapy, appropriate modalities including intermittent hemodialysis, slow continuous ultrafiltration, and continuous renal replacement therapy. Key factors like vascular access, solutions, membranes, anticoagulation, and dose are discussed. The overall conclusions are that while data from high-quality randomized controlled trials are still lacking, earlier initiation of renal replacement therapy may aid recovery, and continuous modalities are generally preferred over intermittent hemodialysis for unstable patients. Individualization of
This document provides an introduction, history, and indications for continuous renal replacement therapy (CRRT). It summarizes that CRRT was developed as an alternative to intermittent hemodialysis for critically ill patients. CRRT allows for slow, continuous removal of waste and fluid over many hours compared to brief, intermittent hemodialysis sessions. The document reviews the components of CRRT systems and indications for its use in critically ill patients with conditions like fluid overload, acidosis, hyperkalemia, or multi-organ dysfunction.
The patient is a 49-year-old woman with end-stage renal disease and diabetes who presented with altered mental status. She receives hemodialysis three times per week for a few years. Recently, she has been increasingly tired, weak, and unable to perform daily activities with poor appetite and nausea. On examination, she was pale and swollen with low hemoglobin. Tests found elevated creatinine, BUN, and electrolyte abnormalities. The most probable diagnosis is inadequate hemodialysis, as her symptoms and labs are consistent with worsening uremia due to insufficient solute clearance from her dialysis sessions. Kt/V is a measure of dialysis adequacy that accounts for urea clearance and patient
Value Analysis Committee Presentation - PleuraFlow® ACT® SystemPaul Molloy
Presentation explaining how the PleuraFlow® ACT® System from ClearFlow,Inc.can Reduce Complications and Costs for your Cardiothoracic surgery patients.
This document discusses continuous renal replacement therapy (CRRT) for acute kidney injury (AKI). It begins by defining CRRT and describing its indications, including life-threatening conditions like hyperkalemia and pulmonary edema. It recommends starting CRRT early in AKI and discusses modalities like CVVH, CVVHD, and CVVHDF. The document provides details on how to perform CRRT, such as catheter placement and settings. It also addresses complications and suggests using bicarbonate-based fluids and biocompatible membranes. In summary, the document provides a comprehensive overview of CRRT for AKI, including indications, modalities, procedures, and recommendations to optimize outcomes.
The Emerging Role of BIomarkers and Bio-Impedancedrucsamal
This document discusses methods for assessing hydration status in patients with acute heart failure. It reviews classical assessment methods like history, physical exam, imaging techniques, and isotopic tracers, which is the gold standard but impractical. It then focuses on emerging roles of biomarkers and bioimpedance analysis which provide a less invasive way to estimate total body water content and fluid overload. These novel methods show promise for diagnosing, risk-stratifying, and guiding treatment decisions for acute heart failure patients.
Dr. Frederic Michard discusses perioperative fluid management and optimization. He advocates using pulse pressure variation (PPV) or stroke volume variation (SVV) to guide fluid administration when possible. When those values cannot be used, stroke volume response to fluid challenges should be monitored. Compliance to fluid optimization protocols is important. Graphical displays and checklists may improve compliance, while closed-loop systems could achieve near 100% compliance, but their safety requires further clinical studies.
The document outlines the objectives and key concepts of a training course on continuous renal replacement therapy (CRRT). It defines CRRT and discusses the basic principles of CRRT, including solute transport mechanisms, clinical indications, machine setup and safety features, and fluid balance principles. It also summarizes evidenced-based research showing improved patient survival with early CRRT initiation and adequate dose delivery.
Comparison Between Antiviral Combination Therapies Against Hepatitis C Virus ...Mohammed Fathy Zaky
This document appears to be a thesis submitted for a degree from the Faculty of Medicine at Ain Shams University in Egypt. It summarizes a clinical study that compared the efficacy and safety of different antiviral combination therapies for hepatitis C virus genotype 4 in 1000 Egyptian patients. The study found overall sustained virological response rates above 95% for all treatment regimens. Sofosbuvir combined with ledipasvir or daclatasvir showed the highest response rates, while sofosbuvir with pegylated interferon and ribavirin showed the lowest. Baseline factors like higher albumin, platelets and lower bilirubin, AFP, and fibrosis scores predicted treatment success.
Evolution of blood transfusion in Hospital General San Jorge
Change in blood consume during ten years.
Red cell concentrate, platelets and plasma reduction is possible
Patient Blood Management and Transfusion with common sense
Journal Club Group fffffffffffffffffffffff1.pptxMyThaoAiDoan
This journal club discusses a randomized controlled trial that compared a restrictive fluid strategy with early vasopressor use to a liberal fluid strategy in patients with sepsis-induced hypotension. The trial found no significant difference in mortality before discharge home by day 90 between the two strategies. Some strengths were its randomized design and excellent safety outcome reporting. Limitations included being unblinded and possibly underpowered. The results do not strongly support changing clinical practice but add to evidence that a restrictive fluid approach may be safe.
This randomized controlled trial compared the effects of 6% hydroxyethyl starch (HES) and saline for fluid resuscitation in over 7,000 critically ill patients. The primary outcome of 90-day mortality was similar between the HES and saline groups. However, the HES group had significantly higher rates of acute kidney injury, renal replacement therapy use, and pruritus. While HES achieved better intravascular volume expansion initially, it provided no clinical benefit and was associated with worse renal outcomes compared to saline for fluid resuscitation in critically ill patients.
The document describes the development and validation of a new prognostic model called the Lille model to identify patients with severe alcoholic hepatitis who are unlikely to survive when treated with corticosteroids. The model was developed based on data from 320 patients and validated in 118 additional patients. It combines six reproducible variables measured at baseline and at day 7 of treatment - age, renal insufficiency, albumin, prothrombin time, bilirubin, and the change in bilirubin at day 7. The Lille model had an area under the receiver operating characteristic curve of 0.89 for predicting 6-month mortality, outperforming other existing models. It identified a cutoff of 0.45 that distinguished patients with low
Early Goal-Directed Therapy in Septic Shockshivabirdi
Early goal directed therapy (EGDT) aims to balance oxygen delivery and demand through manipulating cardiac preload, afterload and contractility using measures like lactate, base deficit and ScvO2. A study of 263 patients with severe sepsis or septic shock found that those receiving EGDT in the emergency department for at least 6 hours had significantly lower in-hospital, 28-day and 60-day mortality compared to standard therapy. EGDT also resulted in fewer organ dysfunctions, less coagulation abnormalities and cardiovascular collapse.
This document discusses patient blood management (PBM), which is a multidisciplinary approach to optimizing patient care and reducing unnecessary blood transfusions. It has three pillars: optimizing erythropoiesis, minimizing bleeding, and harnessing physiological reserves of anemia. The evidence shows PBM can reduce transfusions by 39% without increasing risks. It has led to reduced transfusions and costs in various settings like cardiac and orthopedic surgery. PBM programs require a multidisciplinary team approach led by specialties like anesthesiology. Overall, PBM provides better patient outcomes while reducing allogeneic blood use.
This document provides information on implementing a single unit transfusion guideline to reduce unnecessary transfusions. It discusses assessing patients after a single unit transfusion before giving additional units, and the benefits of such an approach in reducing transfusion risks and complications. It outlines educating staff, empowering them to question multiple unit requests, collecting transfusion data, and providing feedback to promote adherence to the evidence-based guideline.
This document discusses using intrathoracic impedance measures from implantable cardiac devices to monitor changes in intravascular fluid volume during volume reduction therapy for heart failure patients. It found that two impedance vectors, between the right atrial ring to left ventricular ring and the left ventricular ring to right ventricular ring, were most closely associated with changes in plasma volume as measured by hematocrit levels. Monitoring these specific impedance vectors may help more accurately guide volume reduction therapy by tracking changes in the intravascular fluid compartment.
This study analyzed trends in complications from 2000-2012 using a nationwide database of inpatient therapeutic ERCP procedures in the US. The study found:
1) Mortality rates decreased from 1.77% to 1.24%, and time series analysis confirmed this downward trend.
2) Perforation rates increased from 0.07% to 0.10% but time series analysis found no significant trend.
3) GI hemorrhage rates increased from 1.36% to 1.57% and time series analysis confirmed an upward trend.
The study concluded that while therapeutic ERCPs have become safer as shown by decreasing mortality rates, GI hemorrhage rates increased over the same period according to their analysis of
Jafron provides solutions for poisoning Paraquat Poisoning Treatment iNDIA HA230 removes poisons and excessive drugs It is applicable for drug overdose, biotoxin, pesticides, etc For Opinion or consultation @ +86 (756) 3689708
Successful Treatment of Paraquat Poisoning
Hemperfusion - The Key to Successful Treatment of Paraquat Poisoning
Jafron HA230 efficiently absorbs toxin in blood and relieves the symptoms of acute poisoning.
Clinical Practices prove an ideal efficacy of jafron HA230 in drug poisoning and intoxication caused by fat soluble poision or toxicant that is easily combined with plasma protein.
Blood Purification for Paraquat Poisoning
Jafron HA230 efficiently absorbs toxin in blood and relieves the symptoms of acute poisoning.
Clinical Practices prove an ideal efficacy of jafron HA230 in drug poisoning and intoxication caused by fat soluble poision or toxicant that is easily combined with plasma protein.
This multicenter retrospective study evaluated the efficacy of conservative treatment, hemoperfusion (HP), and HP combined with continuous veno-venous hemofiltration (HP + CVVH) for acute paraquat (PQ) poisoning. PQ blood levels decreased faster in the HP and HP + CVVH groups compared to conservative treatment alone. Additionally, PQ levels were significantly lower in the HP + CVVH group at 24 hours compared to HP alone. Organ damage, as assessed by changes in sequential organ failure assessment scores, was significantly lower in the HP and HP + CVVH groups. Survival rates at 60 days were highest in the HP + CVVH group at 46.5%.
1) The document discusses a study examining the effect of enhanced external counterpulsation (EECP) therapy on subsequent emergency department visits and hospitalizations in patients with severe angina and left ventricular dysfunction.
2) The study included 450 patients who underwent EECP therapy for refractory angina and had a left ventricular ejection fraction of 40% or less.
3) The results showed that despite the patients' high risk profile, they experienced a substantial reduction in all-cause emergency department visits and hospitalization rates in the 6 months following EECP therapy compared to the 6 months prior to treatment.
1) The document discusses implementing a single unit transfusion guideline based on patient blood management guidelines to reduce risks from excessive blood transfusions.
2) Transfusing one unit of red blood cells and reassessing the patient before additional units can help align practice with guidelines and reduce transfusion risks like infections and circulatory overload that increase with each unit transfused.
3) Key steps to implement the guideline include designating responsibilities, promoting endorsement from leadership, educating staff, empowering nurses and labs to question additional requests, collecting data to monitor compliance, and providing feedback.
This document discusses the management of variceal bleeding, specifically focusing on esophageal and gastric varices. It provides an overview of endoscopic and medical therapies for controlling acute esophageal variceal bleeding such as endoscopic band ligation, sclerotherapy, and pharmacologic therapies like octreotide. For gastric varices, it describes different classification systems and challenges in managing bleeding, noting endoscopic therapies like sclerotherapy, ligation, and glue injection can control acute bleeding but have high rebleeding risks. It emphasizes a multidisciplinary approach is often needed for gastric variceal management.
AKI, or acute kidney injury, occurs in 18% of hospital admissions and can be caused by sepsis, hypovolemia, drugs, acute glomerulonephritis, or obstruction. Early signs include increased serum creatinine, low blood pressure under 90, and low urine output under 500ml in 24 hours. Treatment focuses on fluid management and supportive care; starting renal replacement therapy is based on fluid overload and high blood urea levels. Continuous renal replacement therapy is preferred for hemodynamic instability while intermittent hemodialysis enables faster clearance but is riskier for unstable patients.
dr Franciscus Ginting - Sepsis PIN PAPDI Surabaya WS-051019.pdfcorinafiqliyin
Penegakan diagnosis sepsis sangat diperlukan dalam kasus sepsis itu sendiri. Sepsis dapat disebabkan oleh beberapa hal. Salah satu komplikasi yang dapat timbul adalah syok sepis
Similar to VAMPIRISM IN ICU. Anexus. Firenze, Italia. Aprin 2017 (20)
Clase VIA RICA Y PBMA. VIII Edición de Curso CASTYM-PBM de los Cursos Extraordinarios de Verano de la Universidad de Zaragoza en la sede de Jaca. Julio 2023
Clase DO NOT DO en Hemoterapia y PBM. VIII Edición de Curso CASTYM-PBM de los Cursos Extraordinarios de Verano de la Universidad de Zaragoza en la sede de Jaca. Julio 2023
Clase presentación VIII Edición de Curso CASTYM-PBM de los Cursos Extraordinarios de Verano de la Universidad de Zaragoza en la sede de Jaca. Julio 2023
Manejo de la ANEMIA Y DE LA FERROPENIA EN LA HEMORRAGIA DIGESTIVA
PROtocolos asistenciales para mejorar la GESTión interdisciplinar de las enfermedades DIGestivas en el ámbito hospitalario
Asociación Española de Gastroenterologia
Anemia en distintos contextos médico-quirúrgicos. Experiencias Clínicas:
Manejo de la Anemia y Déficit de hierro (III): en paciente urológica. Dr Oliva
1. El documento describe varias enfermedades poco frecuentes que predisponen a la trombosis como las neoplasias mieloproliferativas crónicas como la policitemia vera y la trombocitemia esencial que presentan un aumento de glóbulos rojos y plaquetas respectivamente.
2. Estas enfermedades comparten características como la sobreproducción de células sanguíneas, anomalías citogenéticas y diátesis trombótica.
3. El tratamiento se dirige a reducir
El documento presenta varios casos clínicos de pacientes. Brevemente describe los síntomas, diagnósticos y tratamientos de tres pacientes que acudieron a consulta médica con diferentes problemas de salud.
Lección inaugural: “Patient Blood Management: concepto, componentes e implementación” Prof A. Herrera
“CURSO DE ACTUALIZACIÓN EN PATIENT BLOOD MANAGEMENT”.
Taller CASTYM (Control Avanzado del Sangrado en Trauma y Cirugía Mayor). Tercera Edición
“CURSO DE ACTUALIZACIÓN EN PATIENT BLOOD MANAGEMENT”. Taller CASTYM (Control Avanzado del Sangrado en Trauma y Cirugía Mayor). Tercera Edición
Segundo Pilar del Patient Blood Management: “Optimización de la hemostasia"
Protocolos de Transfusión Masiva. Actualización en Hemorragia Masiva. Dr Páramo
Prevalencia, Consecuencias y Diagnóstico de la anemia y déficit hierro perioperatoria.
Manejo de la Anemia y Déficit de hierro (I): en paciente ortopédico.
Prevalencia, Consecuencias y Diagnóstico de la anemia y déficit hierro perioperatoria
Conceptos y Generalidades de la Hemoterapia y Patient Blood Management.
Manejo de la Anemia y Déficit de hierro (IV): en la hemorragia digestiva. Dr Montoro
Anemia en distintos contextos médico-quirúrgicos. Experiencias Clínicas
“CURSO DE ACTUALIZACIÓN EN PATIENT BLOOD MANAGEMENT”.
Taller CASTYM (Control Avanzado del Sangrado en Trauma y Cirugía Mayor). Tercera Edición
“Nuevas Pruebas”: Test de Generación de Trombina, Técnicas viscoelásticas, t...José Antonio García Erce
“CURSO DE ACTUALIZACIÓN EN PATIENT BLOOD MANAGEMENT”.
Taller CASTYM (Control Avanzado del Sangrado en Trauma y Cirugía Mayor). Tercera Edición
Segundo Pilar del Patient Blood Management: “Optimización de la hemostasia” (I )
“Nuevas Pruebas”: Test de Generación de Trombina, Técnicas viscoelásticas, tromboelastografía y agregometría en la Monitorización. Dra S Villar
“CURSO DE ACTUALIZACIÓN EN PATIENT BLOOD MANAGEMENT”.
Taller CASTYM (Control Avanzado del Sangrado en Trauma y Cirugía Mayor). Tercera Edición
Medidas farmacológicas para la reducción del sangrado: antifibrinolíticos, vasopresina y otros. Dr Páramo
Segundo Pilar del Patient Blood Management: “Optimización de la hemostasia”
Manejo perioperatorio del paciente anticoagulado/antiagregado. “Terapia puent...José Antonio García Erce
Manejo perioperatorio del paciente anticoagulado/antiagregado. “Terapia puente”. Dra S Villar
“CURSO DE ACTUALIZACIÓN EN PATIENT BLOOD MANAGEMENT”.
Taller CASTYM (Control Avanzado del Sangrado en Trauma y Cirugía Mayor). Tercera Edición
Criterios “restrictivos” de transfusión de concentrados de hematíes. Dra AnteloJosé Antonio García Erce
Este documento discute criterios restrictivos para la transfusión de concentrados de hematíes. Presenta la fisiología de los glóbulos rojos y la anemia, aspectos legales de la transfusión, tipos de concentrados de hematíes, riesgos asociados a la transfusión como sobrecarga circulatoria y síndrome de dificultad respiratoria aguda relacionada con la transfusión, y nuevos algoritmos para determinar cuándo una transfusión es necesaria de forma segura y eficaz. El objetivo es mejorar la calidad de la at
Criterios, Indicación y alternativas a la transfusión de plasma y plasma
III Curso Castym-PBM
Universidad de Zaragoza
Cursos Extraordinarios de Verano. Sede Jaca
Julio 2018
¿Esperando para una Hb mejor?
Manejo Anemia Perioperatoria
Conclusiones del Documento de Salamanca de la Rehabilitación Multimodal
http://www.germ2018.es
(1) El documento presenta novedades en la hemoterapia, incluyendo legislación, riesgos infecciosos, y técnicas como la inactivación de patógenos. (2) Revisa temas como la crisis de la oferta y demanda de sangre debido al envejecimiento de donantes y receptores. (3) Analiza estudios sobre la seguridad de técnicas como la inactivación en placquetas.
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
VAMPIRISM IN ICU. Anexus. Firenze, Italia. Aprin 2017
1. Vampirism in the Intensive Care Unit:
A routine practice?
A.M. Ayuso-Alvarez1
, J.A. García Erce2
, S. Gómez-Ramírez3
, A. Sarria4
, M.
Muñoz3
, M. Quintana Díaz1,5
1
Intensive Medicine Service, University Hospital La Paz, Madrid; 2
Blood and Tissue
Bank of Navarra, Pamplona; 3
Perioperative Transfusion Medicine, University of
Málaga, Málaga; 4
National Health School, University of Alcalá (REDISSEC), Alcalá de
Henares; 5
Department of Medicine, Autonomous University, Madrid (Spain).
2. NO INTEREST CONFLICT
Asesor externo
- AMGEN Oncología 2010/2012
- Roche Anemia 2009
- Ditassa-Ferrer 2004
Charlas, estudios investigación y ayudas a congresos
-Vifor-Uriach/Ferralinze/AMGEN
-Janssen-Cilag/Braun/Celgene/Alexion
-Astra-Tech de Aztra Zeneca/Well-Health?/GSK
-Sanofi Aventis/Esteve/Novartis/Octapharma
-Cobe-Caridian/Roche Oncología/AMGEN Oncologia
Miembro del CAT 2002-2005
Miembro del Documento de Sevilla “Alternativas a la Transfusión”
Miembro del Documento Latino Americano de la Anemia
Miembro de GIEMSA/ Secretario AWGE/Socio SETS/AEHH/NATA
Editor Asociado Revista ANEMIA www.revistaanemia.org
Miembro Comité Científico NATA y TATM
Representante de la SEHH en la ONT
Colaborador del Choosing Wisely en Anestesiología
Vampirism in the Intensive Care Unit:
A routine practice?
9. http://www.choosingwisely.org/doctor-patient-lists/
Five Recommendations from the Italian Federation of Associations of Hospital
Internal Medicine (FADOI) - 1st List (2014)
http://www.choosingwiselyitaly.org/PDF/ENGracc/Scheda%20FADOI%20(1)%20english.pdf
4. Don’t repeat chemistry testing in the face of clinical and laboratory stability
2012
Vampirism in the Intensive Care Unit:
A routine practice?
11. Objectives
Vampirism in the Intensive Care Unit:
A routine practice?
To evaluate the prevalence and factors
associated with of Hospital Acquired Anaemia
in patients admitted to Intensive Care Units
(ICU).
12. Methods.
Prospective, cross-sectional observational study performed at 5
Spanish hospitals during a 4-month period.
•Data were collected in successive week-days for 7 weeks.
•All patients with ICU <28 days and >24 hours on the day of assessment were
included.
•Variables:
– Clinical and demographic data,
– Phlebotomies (“drawn”) (number and volume),
– Hb change from admission to discharge (DHb), and
– Red blood cell transfusion (RBCT) requirements were collected.
•Data are mean and SD or 95%CI, or number (percentage).
•Student’s t test, Pearson’s χ2
test and lineal regression were performed.
Vampirism in the Intensive Care Unit:
A routine practice?
13. Results.
Overall, 561 patients (66% male) were included.
Mean age was 58 years;
Mean SOFA at admission 5.7± 0.1
APACHE II score at 24 hours 18.3 ± 0.3.
Mean length of ICU stay was 21 days (95%CI: 19-22 days);
ICU mortality rate 12%.
Most frequent reasons for ICU admission were: neurologic (24%),
respiratory (12%), infectious (12%), or cardiovascular diseases
(10%).
Vampirism in the Intensive Care Unit:
A routine practice?
14. Results.
No anemia Mild
anemia
Moderate
anemia
Severe
anaemia
All
patients
p
Patients, n 196 213 118 34 561 ---
Admission Hb (g/dL) 14.2 11.2 9.3 6.9 11.5 <0.001
Phlebotomy (mL/day) 31 33 30 32 31 0.468
Surgery, n (%) 66 (34) 88 (41) 47 (40) 9 (27) 244 (38) 0.212
Transfusion, n (%) 42 (21) 85 (40) 69 (58) 30 (88) 260 (40) <0.001
RBCT (units/patient) 1.6 1.6 3.0 5.2 2.1 <0.001
ICU stay (days) 21 21 20 22 21 0.916
Discharge Hb (g/dL) 10.5 9.3 8.1 9.0 9.4 <0.001
D Hb (g/dL) -3.0 -1.5 0.1 2.1 -1.5 <0.001
Vampirism in the Intensive Care Unit:
A routine practice?
15. Results: Anaemia at Admission
p<0.001
Vampirism in the Intensive Care Unit:
A routine practice?
19. Results.
Adjusting for Hb at admission, a linear relationship between the extracted
volume / day and the Hb at the discharge (R2 = 0.25, p <0.001) was observed
and on the day of the cut (R2 = 0.43, p <0.001).
Discharged Hb
level
Admission-Discharge Hb
difference
R p R p
ICU admission Hb 0,33 <0,001 -0,67 <0,001
Total extracted mL -0,01 0,007 -0,01 0,007
RCC Transfused (n) -0,022 0,160 -0,022 0,160
With no significant relationship to the number of transfused concentrates.
Vampirism in the Intensive Care Unit:
A routine practice?
PEARSON´S MULTILATERAL CORRELATION
20.
21. Conclusions.
A significant number of phlebotomies are performed among ICU
patients, which associated with the development/maintenance of
"acquired anemia."
Although 40% require RBCT, it seems to be effective at controlling
Hb level only in those with severe anemia at ICU admission.
Vampirism in the Intensive Care Unit:
A routine practice?
Frietz 2014
22. Vampirism in the Intensive Care Unit:
A routine practice?
EPIGRAPH
“All great work is the fruit of patience
and perseverance, combined with
tenacious concentration on a subject
over a period of months or years”
Dr Santiago Ramón y Cajal
Navarra-Aragón
Medicine´s Nobel Prize
Please, DONATe and tranfuse WISELY!
Editor's Notes
10,3 mL/draw; 41,1 mL/24 h; correlation between organ dysfunction between number of blood draws total volumen drawn